Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck KGaA Signs Cancer-MS Barter Deal With Japan's Ono

This article was originally published in The Pink Sheet Daily

Executive Summary

Merck Serono and Ono exchange rights to clinical programs in MS and cancer, with little cash changing hands
Advertisement

Related Content

Sanofi's Oral Aubagio Jostles For Position In Multiple Sclerosis Market
Sanofi's Oral Aubagio Jostles For Position In Multiple Sclerosis Market
Deals Of The Week: Bristol/Ono, Bristol/Ambrx, Merck Serono/Peptimmune
Deals Of The Week: Bristol/Ono, Bristol/Ambrx, Merck Serono/Peptimmune
Gilenya Off And Running, But Keeping Pace Long-Range Is Key
Disappointing Provenge Sales Stir Doubts About Demand
Germany's Merck Scraps MS Drug Cladribine After Regulators' Rebuff

Topics

Advertisement
UsernamePublicRestriction

Register

PS072977

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel